Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$51.28
+0.1%
$53.15
$43.38
$62.88
$6.94B1.08894,518 shs900,460 shs
Haemonetics Co. stock logo
HAE
Haemonetics
$85.07
+1.7%
$79.41
$70.74
$95.26
$4.25B0.36409,869 shs231,275 shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$29.38
+1.4%
$36.28
$27.85
$59.10
$2.28B1.12785,844 shs1.01 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$97.76
+1.4%
$102.12
$78.28
$212.43
$2.35B0.69210,732 shs160,278 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$34.97
+10.2%
$30.30
$13.82
$40.74
$2.05B1.121.26 million shs2.43 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+0.06%-0.98%-1.42%-5.04%-11.72%
Haemonetics Co. stock logo
HAE
Haemonetics
+1.75%+1.02%+5.97%+4.05%+0.32%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
+1.38%-7.67%-12.97%-29.09%-50.02%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+1.43%+1.48%-0.35%+4.97%-46.67%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+10.21%+6.10%+15.57%+51.12%-5.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.7812 of 5 stars
3.31.00.04.12.74.23.1
Haemonetics Co. stock logo
HAE
Haemonetics
4.4102 of 5 stars
2.34.00.04.33.31.72.5
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.9166 of 5 stars
3.15.00.04.02.91.73.8
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.4825 of 5 stars
3.53.00.03.91.92.51.9
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.8885 of 5 stars
1.21.00.04.93.60.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3329.36% Upside
Haemonetics Co. stock logo
HAE
Haemonetics
2.50
Moderate Buy$104.6723.04% Upside
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8952.79% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0025.82% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.33
Hold$37.276.58% Upside

Current Analyst Ratings

Latest GMED, ICUI, TNDM, HAE, and IART Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $40.00
4/12/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
4/3/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$38.00
4/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$31.00 ➝ $38.00
3/26/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00 ➝ $37.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
3/15/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$25.00 ➝ $31.00
3/1/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $41.00
2/29/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $49.00
2/28/2024
ICU Medical, Inc. stock logo
ICUI
ICU Medical
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$134.00 ➝ $136.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$58.00 ➝ $60.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.80$3.61 per share14.21$29.32 per share1.75
Haemonetics Co. stock logo
HAE
Haemonetics
$1.17B3.70$5.06 per share16.81$16.22 per share5.24
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.50$4.90 per share6.00$20.31 per share1.45
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.05$15.54 per share6.29$87.96 per share1.11
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$747.72M3.02N/AN/A$4.81 per share7.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1743.8315.631.517.83%8.82%7.20%5/7/2024 (Confirmed)
Haemonetics Co. stock logo
HAE
Haemonetics
$115.40M$2.4634.5820.061.979.97%22.37%9.71%5/9/2024 (Confirmed)
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8335.408.140.874.39%15.19%6.59%5/6/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A18.17N/A-1.31%6.35%3.03%5/13/2024 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$3.44N/AN/AN/A-29.77%-31.48%-10.75%5/2/2024 (Confirmed)

Latest GMED, ICUI, TNDM, HAE, and IART Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$0.88N/A-$0.88N/AN/AN/A  
5/7/2024N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55N/A-$0.55N/AN/AN/A  
5/6/2024N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.55N/A-$0.55N/AN/AN/A  
5/2/2024N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.80N/A+$0.80N/AN/AN/A  
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/21/2024Q4 2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.23-$0.27-$0.04-$0.08$204.86 million$196.80 million
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    
2/8/202412/31/2023
Haemonetics Co. stock logo
HAE
Haemonetics
$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
Haemonetics Co. stock logo
HAE
Haemonetics
0.91
2.92
1.76
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.91
3.83
3.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%
Haemonetics Co. stock logo
HAE
Haemonetics
1.79%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
Haemonetics Co. stock logo
HAE
Haemonetics
3,03450.79 million49.88 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,40064.56 million62.95 millionOptionable

GMED, ICUI, TNDM, HAE, and IART Headlines

SourceHeadline
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel Nicolaus
americanbankingnews.com - April 24 at 4:02 AM
Tandem Diabetes Care IncTandem Diabetes Care Inc
morningstar.com - April 23 at 10:56 PM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus
marketbeat.com - April 23 at 1:49 PM
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%
marketbeat.com - April 23 at 1:25 PM
Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)
americanbankingnews.com - April 20 at 2:04 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.com
americanbankingnews.com - April 19 at 2:14 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - April 17 at 4:44 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%
marketbeat.com - April 15 at 1:55 PM
Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 15 at 4:26 AM
Validea Detailed Fundamental Analysis - TNDMValidea Detailed Fundamental Analysis - TNDM
nasdaq.com - April 14 at 11:34 AM
Reviewing Tandem Diabetes Care (NASDAQ:TNDM) & iCAD (NASDAQ:ICAD)Reviewing Tandem Diabetes Care (NASDAQ:TNDM) & iCAD (NASDAQ:ICAD)
americanbankingnews.com - April 14 at 1:22 AM
Tandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to SellTandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to Sell
marketbeat.com - April 11 at 11:12 PM
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
businesswire.com - April 9 at 4:05 PM
Whats Driving Tandem Diabetes Care Incs Surprising 25% Stock Rally?What's Driving Tandem Diabetes Care Inc's Surprising 25% Stock Rally?
gurufocus.com - April 9 at 12:02 PM
Bullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of StockBullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of Stock
finance.yahoo.com - April 9 at 8:55 AM
1 Beaten-Down Stock That Could Make You Richer1 Beaten-Down Stock That Could Make You Richer
fool.com - April 7 at 12:07 PM
Should You Invest in Tandem Diabetes Care (TNDM)?Should You Invest in Tandem Diabetes Care (TNDM)?
finance.yahoo.com - April 5 at 9:49 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00
marketbeat.com - April 3 at 3:22 PM
Tandem Mobi automated insulin pump wins FDA nod for expanded pediatric useTandem Mobi automated insulin pump wins FDA nod for expanded pediatric use
drugdeliverybusiness.com - April 2 at 2:43 PM
Chicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Chicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 2 at 6:37 AM
Tandem Diabetes Care (NASDAQ:TNDM)  Shares Down 6.1% Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 6.1%
marketbeat.com - April 1 at 3:48 PM
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro IssuesTandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
zacks.com - April 1 at 11:46 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Rating of "Hold" from BrokeragesTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Rating of "Hold" from Brokerages
marketbeat.com - April 1 at 2:31 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Short Interest UpdateTandem Diabetes Care, Inc. (NASDAQ:TNDM) Short Interest Update
marketbeat.com - March 30 at 10:28 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Haemonetics logo

Haemonetics

NYSE:HAE
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Tandem Diabetes Care logo

Tandem Diabetes Care

NASDAQ:TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.